GO:2000724 positive regulation of cardiac vascular smooth muscle cell differentiation: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000724 describes any process that activates or increases the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation.
• c-Myb is a key transcription factor that drives smooth muscle cell differentiation, and its regulation is central to this process.
• Notch3 signaling regulates the differentiation of aortic vascular stem cells into smooth muscle cells, linking developmental pathways to vascular disease.
• Dysregulation of this process contributes to aortic dissection, vascular calcification, and neointimal hyperplasia [1,5,8].
• Interleukin-18 and the Nrf3-Trim5 axis are emerging regulators of vascular smooth muscle cell dysfunction and osteogenic differentiation [1,5].
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes controlling cardiac vascular smooth muscle cell differentiation.
Description
Cardiac vascular smooth muscle cells (VSMCs) are essential for the structural and functional integrity of blood vessels in the heart. The process by which these cells acquire their specialized contractile phenotype is tightly controlled, and the Gene Ontology term GO:2000724, positive regulation of cardiac vascular smooth muscle cell differentiation, captures any molecular event that enhances this differentiation program. Understanding this process is critical because defects in VSMC differentiation underlie major cardiovascular pathologies, including aortic dissection, vascular calcification, and neointimal hyperplasia [1,5,8]. Research over the past two decades has identified transcription factors, signaling pathways, and epigenetic modifiers that positively regulate VSMC differentiation. For example, c-Myb was shown to promote smooth muscle cell differentiation in a seminal study that linked transcriptional control to vascular development. More recently, Notch3 signaling was found to regulate the differentiation of aortic vascular stem cells into smooth muscle cells, providing a mechanism for how developmental cues maintain vessel wall homeostasis. These findings highlight the importance of GO:2000724 in both normal vascular biology and disease pathogenesis. This article synthesizes the current understanding of GO:2000724, focusing on its definition, biological significance, key genes, regulatory mechanisms, and the experimental models used to study it.
positive regulation of cardiac vascular smooth muscle cell differentiation At A Glance
| GO ID | GO:2000724 |
|---|---|
| GO term | positive regulation of cardiac vascular smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | positive regulation of heart vascular smooth muscle cell differentiation |
| Major function | Enhances the differentiation of vascular smooth muscle cells in the heart, promoting a contractile phenotype. |
| Related process | Smooth muscle cell differentiation (GO:0042692) |
| Related disease | Aortic dissection, vascular calcification, neointimal hyperplasia |
| Key regulators | c-Myb, Notch3, GATA6, Nrf3-Trim5 axis, Interleukin-18 |
What Is GO:2000724?
GO:2000724, positive regulation of cardiac vascular smooth muscle cell differentiation, is a biological process term defined as any process that activates or increases the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation. In other words, it encompasses all molecular signals, transcription factors, and epigenetic changes that push cardiac vascular smooth muscle cells toward a more differentiated, contractile state. This term is a child of the broader regulation of cardiac vascular smooth muscle cell differentiation and is specific to the heart vasculature. It is distinct from negative regulation (GO:2000725) and from differentiation of other smooth muscle cell types. The synonym positive regulation of heart vascular smooth muscle cell differentiation is used interchangeably.
Why Is positive regulation of cardiac vascular smooth muscle cell differentiation Important in Cell Biology?
GO:2000724 is important because the proper differentiation of cardiac vascular smooth muscle cells is essential for maintaining vascular tone and preventing pathological remodeling. When this process is impaired, VSMCs can dedifferentiate, proliferate, and migrate, leading to neointimal hyperplasia, atherosclerosis, and aneurysm formation [1,7]. Conversely, excessive or aberrant differentiation can contribute to vascular calcification, a condition associated with increased cardiovascular mortality [2,5]. Understanding the positive regulators of VSMC differentiation provides mechanistic insights into these diseases and identifies potential therapeutic targets. Moreover, the process is highly relevant to regenerative medicine, where directing stem cells toward a smooth muscle fate is a goal for tissue-engineered vascular grafts.
• Maintains vascular tone and structural integrity of cardiac blood vessels.
• Prevents pathological dedifferentiation of VSMCs that leads to neointimal hyperplasia.
• Dysregulation contributes to aortic dissecting aneurysms via epigenetic modifiers like FTO.
• Interleukin-18 enhances osteogenic differentiation of VSMCs, linking inflammation to vascular calcification.
• Notch3 signaling regulates differentiation of aortic vascular stem cells into smooth muscle cells, impacting aortic dissection.
• c-Kit suppression of atherosclerosis involves effects on VSMC biology.
• GATA6 accelerates VSMC senescence and arterial calcification by counteracting SIRT6.
• Cyclic GMP signaling regulates gene expression in VSMCs, influencing differentiation.
• Nrf3-Trim5 axis modulates VSMC dysfunction and neointimal hyperplasia.
• The process is a target for CRISPR-based screens to identify novel regulators.
What Happens During positive regulation of cardiac vascular smooth muscle cell differentiation?
Initiation by transcription factors
In simple terms: Certain proteins called transcription factors turn on the genes that make a smooth muscle cell specialized.
The positive regulation of cardiac vascular smooth muscle cell differentiation begins with the activation of transcription factors that bind to promoter regions of smooth muscle-specific genes. c-Myb is a well-characterized transcription factor that promotes smooth muscle cell differentiation, as demonstrated in studies showing that c-Myb-dependent transcriptional programs drive the expression of contractile proteins. Similarly, Notch3 signaling regulates the differentiation of aortic vascular stem cells into smooth muscle cells, highlighting the role of developmental signaling pathways in initiating this process. These transcription factors coordinate the expression of genes such as ACTA2, MYH11, and CNN1, which are hallmarks of differentiated VSMCs.
Epigenetic and post-transcriptional control
In simple terms: Chemical tags on DNA and RNA can dial up or down the differentiation program.
Epigenetic modifiers and RNA modifications fine-tune the differentiation process. For instance, the m6A RNA demethylase FTO promotes aortic dissecting aneurysms via m6A modification of Klf5, a transcription factor involved in VSMC biology. This indicates that post-transcriptional regulation of key mRNAs can influence the positive regulation of VSMC differentiation. Additionally, GATA6 accelerates VSMC senescence-related arterial calcification by counteracting SIRT6 and impeding DNA damage repair, suggesting that epigenetic and DNA repair pathways intersect with differentiation control.
Signaling pathways and second messengers
In simple terms: External signals and small molecules inside the cell relay messages to the nucleus to promote differentiation.
Cyclic GMP (cGMP) signaling regulates gene expression in vascular smooth muscle cells, and this pathway can positively influence differentiation. Interleukin-18 enhances vascular calcification and osteogenic differentiation of VSMCs through TRPM7 activation, demonstrating that inflammatory cytokines can shift the differentiation balance toward an osteogenic phenotype. The Nrf3-Trim5 axis has been implicated in VSMC dysfunctions and neointimal hyperplasia, further illustrating how signaling cascades modulate the differentiation state.
Integration with cell cycle and senescence
In simple terms: Differentiation is linked to the cell's decision to stop dividing and to age.
Positive regulation of VSMC differentiation often involves exit from the cell cycle and changes in senescence programs. GATA6 promotes VSMC senescence and arterial calcification, which are associated with altered differentiation states. c-Kit suppresses atherosclerosis in hyperlipidemic mice, potentially by maintaining VSMC in a differentiated state. These findings suggest that the positive regulation of differentiation is tightly coupled to cell cycle arrest and senescence pathways.
Key Genes Involved in GO:2000724 positive regulation of cardiac vascular smooth muscle cell differentiation
The following genes and proteins have been experimentally linked to the positive regulation of cardiac vascular smooth muscle cell differentiation or closely related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| c-Myb | Transcription factor that promotes smooth muscle cell differentiation | Key regulator of VSMC differentiation; target for knockout studies |
| Notch3 | Signaling receptor regulating differentiation of aortic vascular stem cells into smooth muscle cells | Implicated in aortic dissection; potential therapeutic target |
| GATA6 | Transcription factor that accelerates VSMC senescence and arterial calcification | Counteracts SIRT6; linked to vascular calcification |
| SIRT6 | Anti-aging factor that protects against VSMC senescence | Opposes GATA6; potential target for calcification |
| FTO | m6A RNA demethylase that modifies Klf5 mRNA | Promotes aortic dissecting aneurysms via epigenetic regulation |
| Klf5 | Transcription factor involved in VSMC proliferation and differentiation | Target of FTO-mediated m6A modification |
| IL-18 | Inflammatory cytokine that enhances osteogenic differentiation of VSMCs | Activates TRPM7; links inflammation to calcification |
| TRPM7 | Transient receptor potential cation channel | Mediates IL-18 effects on VSMC calcification |
| Nrf3 | Transcription factor involved in VSMC dysfunction | Part of Nrf3-Trim5 axis in neointimal hyperplasia |
| Trim5 | E3 ubiquitin ligase | Interacts with Nrf3 to regulate VSMC dysfunction |
| c-Kit | Receptor tyrosine kinase | Suppresses atherosclerosis in hyperlipidemic mice |
| ACTA2 | Smooth muscle alpha-actin, a contractile protein | Marker of differentiated VSMCs |
| MYH11 | Smooth muscle myosin heavy chain | Marker of differentiated VSMCs |
| CNN1 | Calponin 1, a smooth muscle-specific protein | Marker of differentiated VSMCs |
| cGMP | Second messenger that regulates gene expression | Influences VSMC differentiation |
| SIRT6 | NAD+-dependent deacetylase | Protects against VSMC senescence |
| Notch3 | Transmembrane receptor | Regulates vascular stem cell differentiation |
How Is positive regulation of cardiac vascular smooth muscle cell differentiation Regulated?
The positive regulation of cardiac vascular smooth muscle cell differentiation is controlled by a network of transcription factors, epigenetic modifiers, and signaling pathways. c-Myb acts as a transcriptional activator of smooth muscle-specific genes. Notch3 signaling provides extracellular cues that drive differentiation of vascular stem cells. Cyclic GMP signaling modulates gene expression in VSMCs, potentially through cGMP-dependent protein kinases. Inflammatory cytokines such as Interleukin-18 can shift the balance toward osteogenic differentiation via TRPM7. Epigenetic regulators, including the m6A demethylase FTO, influence the stability of mRNAs encoding transcription factors like Klf5. Additionally, the Nrf3-Trim5 axis and GATA6-SIRT6 interplay highlight the importance of protein degradation and deacetylation in this process [1,2]. These regulatory layers ensure that VSMC differentiation is appropriately timed and reversible when needed.
positive regulation of cardiac vascular smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Notch3 | Aortic dissection | Knockout mouse or rat model; VSMC-specific conditional KO |
| FTO | Aortic dissecting aneurysm | FTO knockout or overexpression in VSMCs; m6A sequencing |
| IL-18 | Vascular calcification | IL-18 knockout mice; VSMC calcification assays |
| GATA6 | Arterial calcification | GATA6 transgenic or knockout mice; senescence markers |
| Nrf3 | Neointimal hyperplasia | Nrf3 knockout mice; carotid artery injury model |
Aortic dissection and aneurysm
Disrupted positive regulation of VSMC differentiation contributes to aortic dissection and aneurysm formation. Notch3 signaling regulates the differentiation of aortic vascular stem cells into smooth muscle cells, and its dysregulation is associated with aortic dissection. FTO promotes aortic dissecting aneurysms via m6A modification of Klf5, linking RNA epigenetic changes to VSMC pathology. These findings suggest that enhancing VSMC differentiation could be protective.
Vascular calcification
Vascular calcification is characterized by osteogenic differentiation of VSMCs, which is often considered a maladaptive form of differentiation. Interleukin-18 enhances vascular calcification and osteogenic differentiation of VSMCs through TRPM7 activation. GATA6 accelerates VSMC senescence-related arterial calcification by counteracting SIRT6. Thus, positive regulation of VSMC differentiation must be tightly balanced to prevent calcification.
Neointimal hyperplasia and atherosclerosis
Neointimal hyperplasia results from excessive proliferation and migration of dedifferentiated VSMCs. The Nrf3-Trim5 axis has been implicated in VSMC dysfunctions and neointimal hyperplasia. c-Kit suppresses atherosclerosis in hyperlipidemic mice, possibly by maintaining VSMCs in a differentiated state. These studies highlight the therapeutic potential of targeting pathways that positively regulate VSMC differentiation.
From positive regulation of cardiac vascular smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate VSMC differentiation? | CRISPR knockout of gene X in primary VSMCs or cell lines, followed by differentiation markers |
| Does a point mutation in gene Y affect its function in VSMC differentiation? | CRISPR point mutation knock-in in VSMCs or iPSCs |
| Does overexpression of gene Z enhance VSMC differentiation? | Lentiviral overexpression in VSMCs or transgenic mouse models |
| What is the role of a specific phosphorylation site in protein W? | CRISPR knock-in of phospho-mutant in VSMCs |
| How does a disease-associated variant affect VSMC differentiation? | CRISPR knock-in of the variant in iPSC-derived VSMCs |
| What is the epigenetic landscape during VSMC differentiation? | CRISPR knockout of epigenetic modifiers (e.g., FTO) combined with ATAC-seq and RNA-seq |
How to Study the positive regulation of cardiac vascular smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify differentiation-induced genes |
| ATAC-seq | Chromatin accessibility | Map regulatory regions during differentiation |
| ChIP-seq | Transcription factor binding sites | Locate c-Myb or Notch3 targets [3,8] |
| MeRIP-seq | m6A RNA methylation | Study FTO-mediated m6A changes |
| Proteomics | Protein abundance and modifications | Quantify contractile proteins |
| Immunofluorescence | Protein localization and expression | Validate VSMC differentiation markers |
| Calcium imaging | Intracellular calcium dynamics | Assess functional VSMC maturation |
| CRISPR screening | Gene function at scale | Identify novel regulators of differentiation |
Transcriptomic profiling
RNA sequencing (RNA-seq) is widely used to measure global gene expression changes during VSMC differentiation. Studies of c-Myb-dependent differentiation have employed RNA-seq to identify target genes. Similarly, RNA-seq can reveal how Notch3 signaling alters the transcriptome of vascular stem cells.
Epigenomic and epitranscriptomic analysis
ATAC-seq and ChIP-seq can map chromatin accessibility and transcription factor binding during differentiation. m6A RNA immunoprecipitation (MeRIP-seq) has been used to study FTO-mediated m6A modification of Klf5 in VSMC pathology. These methods provide mechanistic insights into how epigenetic regulators control differentiation.
Proteomic and phosphoproteomic approaches
Mass spectrometry-based proteomics can quantify contractile protein expression and post-translational modifications. For example, cyclic GMP signaling affects protein phosphorylation, which can be assessed by phosphoproteomics. These techniques help validate findings from transcriptomic studies.
Functional assays and imaging
Immunofluorescence staining for smooth muscle markers (ACTA2, MYH11, CNN1) is standard for assessing differentiation. Calcium imaging and contractility assays can confirm functional maturation. These methods are essential for linking molecular changes to cellular phenotype.
How CRISPR Can Be Used to Study GO:2000724 positive regulation of cardiac vascular smooth muscle cell differentiation
Knockout
CRISPR knockout is used to delete candidate genes and assess their requirement for positive regulation of cardiac VSMC differentiation. For example, knocking out c-Myb in VSMCs would test its necessity for differentiation. Similarly, Notch3 knockout can reveal its role in aortic vascular stem cell differentiation. Knockout models are essential for establishing causality.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific amino acid substitutions to study protein function. For instance, mutating phosphorylation sites in cGMP-dependent protein kinase would help dissect its role in VSMC differentiation. Point mutations can also model human disease variants, such as those in GATA6 linked to calcification.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, FLAG) enables visualization and purification of differentiated VSMCs. Tagging endogenous ACTA2 or MYH11 with fluorescent proteins allows live tracking of differentiation. Knock-in of disease-associated mutations, such as in FTO, can model aortic dissecting aneurysm.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high-level expression of candidate genes to test sufficiency. Overexpressing c-Myb or Notch3 may enhance VSMC differentiation [3,8]. Overexpression of SIRT6 could protect against GATA6-mediated calcification. These approaches complement loss-of-function studies.
How EDITGENE Supports positive regulation of cardiac vascular smooth muscle cell differentiation Research
Researchers studying positive regulation of cardiac vascular smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the differentiation process or is merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal interrogation, from generating knockout cell lines to performing high-throughput library screens.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cardiac vascular smooth muscle cell differentiation research.
Frequently Asked Questions About positive regulation of cardiac vascular smooth muscle cell differentiation
What is GO:2000724?
GO:2000724 is a Gene Ontology term for positive regulation of cardiac vascular smooth muscle cell differentiation, describing any process that increases the rate or extent of this differentiation.
What genes are involved in positive regulation of cardiac vascular smooth muscle cell differentiation?
Key genes include c-Myb, Notch3, GATA6, SIRT6, FTO, Klf5, IL-18, TRPM7, Nrf3, Trim5, and c-Kit [1,2,3,4,5,7,8].
How does Notch3 signaling affect cardiac vascular smooth muscle cell differentiation?
Notch3 signaling regulates the differentiation of aortic vascular stem cells into smooth muscle cells, and its dysregulation is linked to aortic dissection.
What diseases are associated with defects in cardiac vascular smooth muscle cell differentiation?
Aortic dissection, vascular calcification, neointimal hyperplasia, and atherosclerosis are associated with dysregulation of this process [1,2,4,5,7,8].
How can CRISPR be used to study positive regulation of cardiac vascular smooth muscle cell differentiation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of candidate genes in VSMC differentiation [3,6,8].
What is the role of c-Myb in smooth muscle cell differentiation?
c-Myb is a transcription factor that promotes smooth muscle cell differentiation by activating contractile gene expression.
How does FTO influence vascular smooth muscle cells?
FTO promotes aortic dissecting aneurysms via m6A modification of Klf5, affecting VSMC function.
What is the Nrf3-Trim5 axis?
The Nrf3-Trim5 axis is a protein complex that regulates vascular smooth muscle cell dysfunction and neointimal hyperplasia.
Can Interleukin-18 affect vascular calcification?
Yes, Interleukin-18 enhances vascular calcification and osteogenic differentiation of VSMCs through TRPM7 activation.
What methods are used to study cardiac vascular smooth muscle cell differentiation?
Common methods include RNA-seq, ATAC-seq, ChIP-seq, MeRIP-seq, proteomics, immunofluorescence, and CRISPR screens [3,4,6].
Conclusion
GO:2000724, positive regulation of cardiac vascular smooth muscle cell differentiation, is a critical biological process that maintains vascular homeostasis and prevents disease. Research has identified key transcription factors, signaling pathways, and epigenetic modifiers that drive this process, including c-Myb, Notch3, GATA6, and FTO [2,3,4,8]. Dysregulation contributes to aortic dissection, vascular calcification, and neointimal hyperplasia [1,5,8]. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of novel regulators. EDITGENE provides the tools and expertise to dissect these mechanisms, from knockout and knock-in cell lines to library screening and bioinformatics, empowering researchers to translate findings into therapeutic strategies.
References
- 1. Chen Q et al.. 2025. Novel roles of Nrf3-Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia.. Cardiovasc Res 121(8):1282-1298 PMID: 40377016
- 2. Li X et al.. 2024. The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair.. Kidney Int 105(1):115-131 PMID: 37914087
- 3. Kolodziejska KM et al.. 2008. c-Myb-dependent smooth muscle cell differentiation.. Circ Res 102(5):554-61 PMID: 18187733
- 4. Ma D et al.. 2020. Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.. Front Cardiovasc Med 7:592550 PMID: 33330653
- 5. Zhang K et al.. 2017. Interleukin-18 Enhances Vascular Calcification and Osteogenic Differentiation of Vascular Smooth Muscle Cells Through TRPM7 Activation.. Arterioscler Thromb Vasc Biol 37(10):1933-1943 PMID: 28860220
- 6. Pilz RB et al.. 2003. Regulation of gene expression by cyclic GMP.. Circ Res 93(11):1034-46 PMID: 14645134
- 7. Song L et al.. 2019. c-Kit suppresses atherosclerosis in hyperlipidemic mice.. Am J Physiol Heart Circ Physiol 317(4):H867-H876 PMID: 31441677
- 8. Han Y et al.. 2023. [Mechanism of Notch3 signaling pathway regulating the differentiation of aortic dissection vascular stem cells into smooth muscle cells].. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 35(5):503-508 PMID: 37308231
